nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—ABCC2—Glyburide—gestational diabetes	0.187	0.316	CbGbCtD
Sorafenib—ABCG2—Glyburide—gestational diabetes	0.169	0.286	CbGbCtD
Sorafenib—CYP2C19—Glyburide—gestational diabetes	0.0756	0.128	CbGbCtD
Sorafenib—CYP2C9—Glyburide—gestational diabetes	0.0628	0.106	CbGbCtD
Sorafenib—ABCB1—Glyburide—gestational diabetes	0.061	0.103	CbGbCtD
Sorafenib—CYP3A4—Glyburide—gestational diabetes	0.0365	0.0617	CbGbCtD
Sorafenib—Allergic cutaneous angiitis—Glyburide—gestational diabetes	0.00913	0.168	CcSEcCtD
Sorafenib—FLT1—umbilical vein—gestational diabetes	0.00854	0.0402	CbGeAlD
Sorafenib—KDR—umbilical vein—gestational diabetes	0.00722	0.034	CbGeAlD
Sorafenib—CDKL3—adipose tissue—gestational diabetes	0.00602	0.0283	CbGeAlD
Sorafenib—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.00592	0.109	CcSEcCtD
Sorafenib—CDKL2—head—gestational diabetes	0.00423	0.0199	CbGeAlD
Sorafenib—HIPK3—islet of Langerhans—gestational diabetes	0.00384	0.018	CbGeAlD
Sorafenib—MAPK15—head—gestational diabetes	0.00381	0.0179	CbGeAlD
Sorafenib—CDK7—uterus—gestational diabetes	0.00296	0.0139	CbGeAlD
Sorafenib—MAPK11—adipose tissue—gestational diabetes	0.00294	0.0138	CbGeAlD
Sorafenib—CDK7—adipose tissue—gestational diabetes	0.00289	0.0136	CbGeAlD
Sorafenib—TAOK2—adipose tissue—gestational diabetes	0.00287	0.0135	CbGeAlD
Sorafenib—FLT4—embryo—gestational diabetes	0.00286	0.0135	CbGeAlD
Sorafenib—MKNK2—islet of Langerhans—gestational diabetes	0.00268	0.0126	CbGeAlD
Sorafenib—ZAK—uterus—gestational diabetes	0.00256	0.012	CbGeAlD
Sorafenib—RET—embryo—gestational diabetes	0.00253	0.0119	CbGeAlD
Sorafenib—ZAK—adipose tissue—gestational diabetes	0.0025	0.0118	CbGeAlD
Sorafenib—HIPK3—adipose tissue—gestational diabetes	0.00245	0.0115	CbGeAlD
Sorafenib—RALBP1—islet of Langerhans—gestational diabetes	0.00242	0.0114	CbGeAlD
Sorafenib—Hepatic function abnormal—Glyburide—gestational diabetes	0.00241	0.0444	CcSEcCtD
Sorafenib—TAOK2—vagina—gestational diabetes	0.00239	0.0112	CbGeAlD
Sorafenib—Hepatic failure—Glyburide—gestational diabetes	0.00235	0.0432	CcSEcCtD
Sorafenib—TIE1—uterus—gestational diabetes	0.00234	0.011	CbGeAlD
Sorafenib—FLT1—islet of Langerhans—gestational diabetes	0.0023	0.0108	CbGeAlD
Sorafenib—RAF1—islet of Langerhans—gestational diabetes	0.00229	0.0108	CbGeAlD
Sorafenib—TIE1—adipose tissue—gestational diabetes	0.00229	0.0107	CbGeAlD
Sorafenib—Renal failure acute—Glyburide—gestational diabetes	0.00228	0.042	CcSEcCtD
Sorafenib—EPHB6—islet of Langerhans—gestational diabetes	0.00228	0.0107	CbGeAlD
Sorafenib—MAPK11—head—gestational diabetes	0.00226	0.0106	CbGeAlD
Sorafenib—BRAF—uterus—gestational diabetes	0.00224	0.0105	CbGeAlD
Sorafenib—FLT1—embryo—gestational diabetes	0.00223	0.0105	CbGeAlD
Sorafenib—CDK7—head—gestational diabetes	0.00222	0.0104	CbGeAlD
Sorafenib—RAF1—embryo—gestational diabetes	0.00221	0.0104	CbGeAlD
Sorafenib—BRAF—adipose tissue—gestational diabetes	0.00219	0.0103	CbGeAlD
Sorafenib—AURKC—head—gestational diabetes	0.00219	0.0103	CbGeAlD
Sorafenib—EPHX2—uterus—gestational diabetes	0.00214	0.0101	CbGeAlD
Sorafenib—Hyponatraemia—Glyburide—gestational diabetes	0.00212	0.039	CcSEcCtD
Sorafenib—EPHX2—adipose tissue—gestational diabetes	0.00209	0.00985	CbGeAlD
Sorafenib—PDGFRA—embryo—gestational diabetes	0.00209	0.00981	CbGeAlD
Sorafenib—ZAK—vagina—gestational diabetes	0.00208	0.00977	CbGeAlD
Sorafenib—HIPK3—vagina—gestational diabetes	0.00203	0.00956	CbGeAlD
Sorafenib—EPHA6—head—gestational diabetes	0.00203	0.00952	CbGeAlD
Sorafenib—ZAK—head—gestational diabetes	0.00192	0.00903	CbGeAlD
Sorafenib—FGFR1—uterus—gestational diabetes	0.00191	0.00896	CbGeAlD
Sorafenib—FLT4—adipose tissue—gestational diabetes	0.00189	0.00888	CbGeAlD
Sorafenib—KDR—embryo—gestational diabetes	0.00188	0.00885	CbGeAlD
Sorafenib—FGFR1—adipose tissue—gestational diabetes	0.00186	0.00876	CbGeAlD
Sorafenib—MAP3K19—head—gestational diabetes	0.00184	0.00865	CbGeAlD
Sorafenib—CSF1R—embryo—gestational diabetes	0.00184	0.00864	CbGeAlD
Sorafenib—BRAF—vagina—gestational diabetes	0.00182	0.00857	CbGeAlD
Sorafenib—MAP3K7—uterus—gestational diabetes	0.0018	0.00848	CbGeAlD
Sorafenib—Pancreatitis—Glyburide—gestational diabetes	0.00179	0.0329	CcSEcCtD
Sorafenib—MAP3K7—adipose tissue—gestational diabetes	0.00176	0.0083	CbGeAlD
Sorafenib—TIE1—head—gestational diabetes	0.00176	0.00825	CbGeAlD
Sorafenib—MKNK2—uterus—gestational diabetes	0.00175	0.00822	CbGeAlD
Sorafenib—EPHX2—vagina—gestational diabetes	0.00174	0.00819	CbGeAlD
Sorafenib—MKNK2—adipose tissue—gestational diabetes	0.00171	0.00804	CbGeAlD
Sorafenib—MKNK1—adipose tissue—gestational diabetes	0.00169	0.00794	CbGeAlD
Sorafenib—PDGFRB—islet of Langerhans—gestational diabetes	0.00169	0.00792	CbGeAlD
Sorafenib—KIT—embryo—gestational diabetes	0.00167	0.00785	CbGeAlD
Sorafenib—PDGFRB—embryo—gestational diabetes	0.00163	0.00766	CbGeAlD
Sorafenib—Jaundice—Glyburide—gestational diabetes	0.00158	0.0292	CcSEcCtD
Sorafenib—RALBP1—uterus—gestational diabetes	0.00158	0.00742	CbGeAlD
Sorafenib—FGFR1—vagina—gestational diabetes	0.00155	0.00728	CbGeAlD
Sorafenib—RALBP1—adipose tissue—gestational diabetes	0.00154	0.00726	CbGeAlD
Sorafenib—FLT1—uterus—gestational diabetes	0.0015	0.00706	CbGeAlD
Sorafenib—RAF1—uterus—gestational diabetes	0.00149	0.00702	CbGeAlD
Sorafenib—FLT1—adipose tissue—gestational diabetes	0.00147	0.00691	CbGeAlD
Sorafenib—MAP3K7—vagina—gestational diabetes	0.00147	0.0069	CbGeAlD
Sorafenib—RAF1—adipose tissue—gestational diabetes	0.00146	0.00687	CbGeAlD
Sorafenib—EPHB6—adipose tissue—gestational diabetes	0.00145	0.00683	CbGeAlD
Sorafenib—FLT4—head—gestational diabetes	0.00145	0.00682	CbGeAlD
Sorafenib—STK10—uterus—gestational diabetes	0.00142	0.00668	CbGeAlD
Sorafenib—MKNK2—vagina—gestational diabetes	0.00142	0.00668	CbGeAlD
Sorafenib—PDGFRA—uterus—gestational diabetes	0.00141	0.00662	CbGeAlD
Sorafenib—MKNK1—vagina—gestational diabetes	0.0014	0.0066	CbGeAlD
Sorafenib—STK10—adipose tissue—gestational diabetes	0.00139	0.00654	CbGeAlD
Sorafenib—PDGFRA—adipose tissue—gestational diabetes	0.00138	0.00647	CbGeAlD
Sorafenib—MKNK2—head—gestational diabetes	0.00131	0.00617	CbGeAlD
Sorafenib—MKNK1—head—gestational diabetes	0.0013	0.0061	CbGeAlD
Sorafenib—Alopecia—Glyburide—gestational diabetes	0.00129	0.0237	CcSEcCtD
Sorafenib—RALBP1—vagina—gestational diabetes	0.00128	0.00604	CbGeAlD
Sorafenib—RET—head—gestational diabetes	0.00128	0.00602	CbGeAlD
Sorafenib—KDR—uterus—gestational diabetes	0.00127	0.00597	CbGeAlD
Sorafenib—Erythema—Glyburide—gestational diabetes	0.00127	0.0234	CcSEcCtD
Sorafenib—Malnutrition—Glyburide—gestational diabetes	0.00127	0.0234	CcSEcCtD
Sorafenib—KDR—adipose tissue—gestational diabetes	0.00124	0.00584	CbGeAlD
Sorafenib—MAP2K5—adipose tissue—gestational diabetes	0.00124	0.00584	CbGeAlD
Sorafenib—CSF1R—uterus—gestational diabetes	0.00124	0.00583	CbGeAlD
Sorafenib—FLT1—vagina—gestational diabetes	0.00122	0.00574	CbGeAlD
Sorafenib—RAF1—vagina—gestational diabetes	0.00121	0.00571	CbGeAlD
Sorafenib—CSF1R—adipose tissue—gestational diabetes	0.00121	0.0057	CbGeAlD
Sorafenib—EPHB6—vagina—gestational diabetes	0.00121	0.00568	CbGeAlD
Sorafenib—RALBP1—head—gestational diabetes	0.00119	0.00558	CbGeAlD
Sorafenib—Anaemia—Glyburide—gestational diabetes	0.00117	0.0216	CcSEcCtD
Sorafenib—Angioedema—Glyburide—gestational diabetes	0.00116	0.0214	CcSEcCtD
Sorafenib—STK10—vagina—gestational diabetes	0.00116	0.00543	CbGeAlD
Sorafenib—PDGFRA—vagina—gestational diabetes	0.00114	0.00538	CbGeAlD
Sorafenib—Leukopenia—Glyburide—gestational diabetes	0.00114	0.0209	CcSEcCtD
Sorafenib—FLT1—head—gestational diabetes	0.00113	0.0053	CbGeAlD
Sorafenib—KIT—uterus—gestational diabetes	0.00113	0.00529	CbGeAlD
Sorafenib—RAF1—head—gestational diabetes	0.00112	0.00527	CbGeAlD
Sorafenib—EPHB6—head—gestational diabetes	0.00112	0.00524	CbGeAlD
Sorafenib—KIT—adipose tissue—gestational diabetes	0.0011	0.00517	CbGeAlD
Sorafenib—PDGFRB—uterus—gestational diabetes	0.0011	0.00517	CbGeAlD
Sorafenib—Myalgia—Glyburide—gestational diabetes	0.00108	0.0199	CcSEcCtD
Sorafenib—Arthralgia—Glyburide—gestational diabetes	0.00108	0.0199	CcSEcCtD
Sorafenib—PDGFRB—adipose tissue—gestational diabetes	0.00107	0.00505	CbGeAlD
Sorafenib—STK10—head—gestational diabetes	0.00107	0.00502	CbGeAlD
Sorafenib—PDGFRA—head—gestational diabetes	0.00106	0.00497	CbGeAlD
Sorafenib—MAP2K5—vagina—gestational diabetes	0.00103	0.00485	CbGeAlD
Sorafenib—KDR—vagina—gestational diabetes	0.00103	0.00485	CbGeAlD
Sorafenib—Shock—Glyburide—gestational diabetes	0.00102	0.0188	CcSEcCtD
Sorafenib—Nervous system disorder—Glyburide—gestational diabetes	0.00102	0.0187	CcSEcCtD
Sorafenib—Thrombocytopenia—Glyburide—gestational diabetes	0.00101	0.0187	CcSEcCtD
Sorafenib—CSF1R—vagina—gestational diabetes	0.00101	0.00474	CbGeAlD
Sorafenib—Anorexia—Glyburide—gestational diabetes	0.000988	0.0182	CcSEcCtD
Sorafenib—KDR—head—gestational diabetes	0.000954	0.00448	CbGeAlD
Sorafenib—MAP2K5—head—gestational diabetes	0.000954	0.00448	CbGeAlD
Sorafenib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000944	0.0174	CcSEcCtD
Sorafenib—CSF1R—head—gestational diabetes	0.000931	0.00438	CbGeAlD
Sorafenib—Dyspnoea—Glyburide—gestational diabetes	0.000924	0.017	CcSEcCtD
Sorafenib—KIT—vagina—gestational diabetes	0.000915	0.0043	CbGeAlD
Sorafenib—Dyspepsia—Glyburide—gestational diabetes	0.000912	0.0168	CcSEcCtD
Sorafenib—Decreased appetite—Glyburide—gestational diabetes	0.000901	0.0166	CcSEcCtD
Sorafenib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000895	0.0165	CcSEcCtD
Sorafenib—PDGFRB—vagina—gestational diabetes	0.000894	0.0042	CbGeAlD
Sorafenib—CYP3A5—islet of Langerhans—gestational diabetes	0.000879	0.00413	CbGeAlD
Sorafenib—ABCC4—uterus—gestational diabetes	0.000875	0.00411	CbGeAlD
Sorafenib—HTR2B—uterus—gestational diabetes	0.00087	0.00409	CbGeAlD
Sorafenib—ABCC4—adipose tissue—gestational diabetes	0.000856	0.00402	CbGeAlD
Sorafenib—HTR2B—adipose tissue—gestational diabetes	0.000851	0.004	CbGeAlD
Sorafenib—Gastrointestinal pain—Glyburide—gestational diabetes	0.000847	0.0156	CcSEcCtD
Sorafenib—KIT—head—gestational diabetes	0.000845	0.00397	CbGeAlD
Sorafenib—PDGFRB—head—gestational diabetes	0.000825	0.00388	CbGeAlD
Sorafenib—Urticaria—Glyburide—gestational diabetes	0.000823	0.0152	CcSEcCtD
Sorafenib—Abdominal pain—Glyburide—gestational diabetes	0.000819	0.0151	CcSEcCtD
Sorafenib—Hypersensitivity—Glyburide—gestational diabetes	0.000763	0.0141	CcSEcCtD
Sorafenib—Asthenia—Glyburide—gestational diabetes	0.000743	0.0137	CcSEcCtD
Sorafenib—Pruritus—Glyburide—gestational diabetes	0.000733	0.0135	CcSEcCtD
Sorafenib—Diarrhoea—Glyburide—gestational diabetes	0.000709	0.0131	CcSEcCtD
Sorafenib—HTR2B—vagina—gestational diabetes	0.000708	0.00333	CbGeAlD
Sorafenib—HTR2C—head—gestational diabetes	0.000696	0.00327	CbGeAlD
Sorafenib—Vomiting—Glyburide—gestational diabetes	0.000659	0.0121	CcSEcCtD
Sorafenib—ABCC4—head—gestational diabetes	0.000657	0.00309	CbGeAlD
Sorafenib—HTR2B—head—gestational diabetes	0.000654	0.00307	CbGeAlD
Sorafenib—Rash—Glyburide—gestational diabetes	0.000653	0.012	CcSEcCtD
Sorafenib—Dermatitis—Glyburide—gestational diabetes	0.000653	0.012	CcSEcCtD
Sorafenib—Headache—Glyburide—gestational diabetes	0.000649	0.0119	CcSEcCtD
Sorafenib—ABCG2—uterus—gestational diabetes	0.000618	0.0029	CbGeAlD
Sorafenib—Nausea—Glyburide—gestational diabetes	0.000615	0.0113	CcSEcCtD
Sorafenib—ABCG2—adipose tissue—gestational diabetes	0.000604	0.00284	CbGeAlD
Sorafenib—CYP2C19—vagina—gestational diabetes	0.000592	0.00278	CbGeAlD
Sorafenib—CYP3A5—adipose tissue—gestational diabetes	0.000561	0.00264	CbGeAlD
Sorafenib—CYP2C8—vagina—gestational diabetes	0.000517	0.00243	CbGeAlD
Sorafenib—ABCG2—vagina—gestational diabetes	0.000502	0.00236	CbGeAlD
Sorafenib—ABCB1—islet of Langerhans—gestational diabetes	0.000467	0.0022	CbGeAlD
Sorafenib—CYP3A5—vagina—gestational diabetes	0.000466	0.00219	CbGeAlD
Sorafenib—CYP2B6—vagina—gestational diabetes	0.000463	0.00218	CbGeAlD
Sorafenib—ABCB1—embryo—gestational diabetes	0.000452	0.00212	CbGeAlD
Sorafenib—CYP2B6—head—gestational diabetes	0.000428	0.00201	CbGeAlD
Sorafenib—CYP2D6—head—gestational diabetes	0.000318	0.0015	CbGeAlD
Sorafenib—ABCB1—uterus—gestational diabetes	0.000305	0.00143	CbGeAlD
Sorafenib—ABCB1—adipose tissue—gestational diabetes	0.000298	0.0014	CbGeAlD
Sorafenib—ABCB1—vagina—gestational diabetes	0.000248	0.00116	CbGeAlD
Sorafenib—ABCB1—head—gestational diabetes	0.000229	0.00108	CbGeAlD
Sorafenib—RAF1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000129	0.000913	CbGpPWpGaD
Sorafenib—RAF1—Signaling by PDGF—FGF2—gestational diabetes	0.000128	0.000909	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—GGCT—gestational diabetes	0.000127	0.000904	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—GGCT—gestational diabetes	0.000127	0.000904	CbGpPWpGaD
Sorafenib—MAP3K7—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000127	0.000904	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000126	0.000897	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000126	0.000894	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—LEPR—gestational diabetes	0.000125	0.000888	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—MBL2—gestational diabetes	0.000124	0.000879	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	0.000123	0.000875	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—ADIPOQ—gestational diabetes	0.000122	0.000867	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—LEPR—gestational diabetes	0.000122	0.000865	CbGpPWpGaD
Sorafenib—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000122	0.000865	CbGpPWpGaD
Sorafenib—BRAF—MAPK Signaling Pathway—TNF—gestational diabetes	0.00012	0.000853	CbGpPWpGaD
Sorafenib—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00012	0.000853	CbGpPWpGaD
Sorafenib—KIT—Signaling by NGF—FGF2—gestational diabetes	0.000117	0.000833	CbGpPWpGaD
Sorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000116	0.000823	CbGpPWpGaD
Sorafenib—BRAF—Disease—RBP4—gestational diabetes	0.000114	0.000811	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000113	0.000804	CbGpPWpGaD
Sorafenib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000112	0.000795	CbGpPWpGaD
Sorafenib—KIT—Immune System—MBL2—gestational diabetes	0.000112	0.000793	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—MBL2—gestational diabetes	0.000112	0.000793	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by NGF—FGF2—gestational diabetes	0.000111	0.000791	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—GLS2—gestational diabetes	0.000111	0.00079	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—GLS2—gestational diabetes	0.000111	0.00079	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by NGF—FGF2—gestational diabetes	0.000111	0.000789	CbGpPWpGaD
Sorafenib—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000111	0.000789	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—LEP—gestational diabetes	0.000111	0.000786	CbGpPWpGaD
Sorafenib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00011	0.000785	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—GCK—gestational diabetes	0.00011	0.00078	CbGpPWpGaD
Sorafenib—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000109	0.000778	CbGpPWpGaD
Sorafenib—MAP3K7—MAPK Signaling Pathway—TNF—gestational diabetes	0.000109	0.000777	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—GGCT—gestational diabetes	0.000108	0.000767	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—AR—gestational diabetes	0.000108	0.000764	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—GGCT—gestational diabetes	0.000107	0.000761	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000106	0.000755	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—MBL2—gestational diabetes	0.000106	0.000752	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—MBL2—gestational diabetes	0.000106	0.00075	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—LEPR—gestational diabetes	0.000105	0.000744	CbGpPWpGaD
Sorafenib—KIT—Disease—RBP4—gestational diabetes	0.000104	0.000738	CbGpPWpGaD
Sorafenib—FGFR1—MAPK Signaling Pathway—TNF—gestational diabetes	0.000104	0.000737	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—LEPR—gestational diabetes	0.000104	0.000737	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—MTNR1B—gestational diabetes	0.000103	0.00073	CbGpPWpGaD
Sorafenib—BRAF—Disease—NAMPT—gestational diabetes	0.000102	0.000727	CbGpPWpGaD
Sorafenib—BRAF—Disease—GCK—gestational diabetes	0.000102	0.000723	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by NGF—FGF2—gestational diabetes	0.0001	0.000711	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.95e-05	0.000707	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—MTNR1B—gestational diabetes	9.88e-05	0.000702	CbGpPWpGaD
Sorafenib—FGFR1—Disease—RBP4—gestational diabetes	9.86e-05	0.0007	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—RBP4—gestational diabetes	9.83e-05	0.000699	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—FGF2—gestational diabetes	9.77e-05	0.000694	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—TNF—gestational diabetes	9.74e-05	0.000692	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—RBP4—gestational diabetes	9.63e-05	0.000684	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—MTNR1B—gestational diabetes	9.63e-05	0.000684	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—MTNR1B—gestational diabetes	9.61e-05	0.000682	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—MBL2—gestational diabetes	9.52e-05	0.000676	CbGpPWpGaD
Sorafenib—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	9.49e-05	0.000674	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—LEP—gestational diabetes	9.46e-05	0.000672	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—LEPR—gestational diabetes	9.44e-05	0.000671	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—LEPR—gestational diabetes	9.44e-05	0.000671	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—GLS2—gestational diabetes	9.44e-05	0.000671	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—RBP4—gestational diabetes	9.38e-05	0.000666	CbGpPWpGaD
Sorafenib—FGFR1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.36e-05	0.000665	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—GLS2—gestational diabetes	9.36e-05	0.000665	CbGpPWpGaD
Sorafenib—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	9.36e-05	0.000665	CbGpPWpGaD
Sorafenib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.34e-05	0.000663	CbGpPWpGaD
Sorafenib—PDGFRB—MAPK Signaling Pathway—TNF—gestational diabetes	9.32e-05	0.000662	CbGpPWpGaD
Sorafenib—KIT—Disease—NAMPT—gestational diabetes	9.32e-05	0.000662	CbGpPWpGaD
Sorafenib—KIT—Disease—GCK—gestational diabetes	9.26e-05	0.000658	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—TNF—gestational diabetes	9.16e-05	0.00065	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—MTNR1B—gestational diabetes	9.13e-05	0.000649	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—LEPR—gestational diabetes	8.96e-05	0.000637	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—LEPR—gestational diabetes	8.94e-05	0.000635	CbGpPWpGaD
Sorafenib—RAF1—Signaling by NGF—FGF2—gestational diabetes	8.92e-05	0.000633	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—RBP4—gestational diabetes	8.86e-05	0.000629	CbGpPWpGaD
Sorafenib—FGFR1—Disease—NAMPT—gestational diabetes	8.84e-05	0.000628	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—NAMPT—gestational diabetes	8.82e-05	0.000627	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	8.82e-05	0.000626	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	8.82e-05	0.000626	CbGpPWpGaD
Sorafenib—FGFR1—Disease—GCK—gestational diabetes	8.79e-05	0.000624	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—GCK—gestational diabetes	8.76e-05	0.000623	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—LEP—gestational diabetes	8.76e-05	0.000622	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—LEP—gestational diabetes	8.62e-05	0.000612	CbGpPWpGaD
Sorafenib—RAF1—Immune System—MBL2—gestational diabetes	8.48e-05	0.000603	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—FGF2—gestational diabetes	8.4e-05	0.000597	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—TNF—gestational diabetes	8.31e-05	0.00059	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—MTNR1B—gestational diabetes	8.29e-05	0.000589	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—MTNR1B—gestational diabetes	8.28e-05	0.000588	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—MTNR1B—gestational diabetes	8.2e-05	0.000583	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—RBP4—gestational diabetes	8.07e-05	0.000573	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—LEPR—gestational diabetes	8.05e-05	0.000572	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—RBP4—gestational diabetes	7.99e-05	0.000568	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—NAMPT—gestational diabetes	7.95e-05	0.000564	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GGCT—gestational diabetes	7.92e-05	0.000562	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—GCK—gestational diabetes	7.9e-05	0.000561	CbGpPWpGaD
Sorafenib—RAF1—Disease—RBP4—gestational diabetes	7.9e-05	0.000561	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—AR—gestational diabetes	7.87e-05	0.000559	CbGpPWpGaD
Sorafenib—MKNK1—Disease—FGF2—gestational diabetes	7.75e-05	0.00055	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GGCT—gestational diabetes	7.74e-05	0.00055	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—LEPR—gestational diabetes	7.68e-05	0.000546	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—LEP—gestational diabetes	7.58e-05	0.000538	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	7.5e-05	0.000533	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MTNR1B—gestational diabetes	7.47e-05	0.00053	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MTNR1B—gestational diabetes	7.47e-05	0.00053	CbGpPWpGaD
Sorafenib—MAPK11—Innate Immune System—FGF2—gestational diabetes	7.42e-05	0.000527	CbGpPWpGaD
Sorafenib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	7.32e-05	0.00052	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—RBP4—gestational diabetes	7.27e-05	0.000517	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—RBP4—gestational diabetes	7.27e-05	0.000517	CbGpPWpGaD
Sorafenib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	7.22e-05	0.000513	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—FGF2—gestational diabetes	7.19e-05	0.000511	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—LEPR—gestational diabetes	7.18e-05	0.00051	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—TNF—gestational diabetes	7.17e-05	0.000509	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—LEP—gestational diabetes	7.14e-05	0.000507	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MTNR1B—gestational diabetes	7.08e-05	0.000503	CbGpPWpGaD
Sorafenib—RAF1—Disease—NAMPT—gestational diabetes	7.08e-05	0.000503	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MTNR1B—gestational diabetes	7.07e-05	0.000502	CbGpPWpGaD
Sorafenib—RAF1—Disease—GCK—gestational diabetes	7.04e-05	0.0005	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GLS2—gestational diabetes	6.92e-05	0.000492	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—RBP4—gestational diabetes	6.9e-05	0.00049	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—RBP4—gestational diabetes	6.89e-05	0.000489	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GLS2—gestational diabetes	6.77e-05	0.000481	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GGCT—gestational diabetes	6.7e-05	0.000476	CbGpPWpGaD
Sorafenib—KIT—Innate Immune System—FGF2—gestational diabetes	6.69e-05	0.000475	CbGpPWpGaD
Sorafenib—MAP3K7—Innate Immune System—FGF2—gestational diabetes	6.69e-05	0.000475	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—FGF2—gestational diabetes	6.65e-05	0.000473	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—FGF2—gestational diabetes	6.55e-05	0.000465	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—LEP—gestational diabetes	6.43e-05	0.000457	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—FGF2—gestational diabetes	6.42e-05	0.000456	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—FGF2—gestational diabetes	6.42e-05	0.000456	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MTNR1B—gestational diabetes	6.37e-05	0.000452	CbGpPWpGaD
Sorafenib—FGFR1—Innate Immune System—FGF2—gestational diabetes	6.35e-05	0.000451	CbGpPWpGaD
Sorafenib—PDGFRA—Innate Immune System—FGF2—gestational diabetes	6.33e-05	0.00045	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—RBP4—gestational diabetes	6.2e-05	0.000441	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—LEPR—gestational diabetes	6.2e-05	0.00044	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—NAMPT—gestational diabetes	6.1e-05	0.000433	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—NAMPT—gestational diabetes	6.1e-05	0.000433	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—FGF2—gestational diabetes	6.1e-05	0.000433	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—FGF2—gestational diabetes	6.08e-05	0.000432	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MTNR1B—gestational diabetes	6.07e-05	0.000431	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—GCK—gestational diabetes	6.06e-05	0.00043	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—GCK—gestational diabetes	6.06e-05	0.00043	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GGCT—gestational diabetes	5.98e-05	0.000425	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—TNF—gestational diabetes	5.95e-05	0.000423	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	5.93e-05	0.000422	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—RBP4—gestational diabetes	5.92e-05	0.00042	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GLS2—gestational diabetes	5.86e-05	0.000416	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GGCT—gestational diabetes	5.84e-05	0.000415	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.81e-05	0.000413	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—FGF2—gestational diabetes	5.76e-05	0.000409	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—FGF2—gestational diabetes	5.71e-05	0.000405	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MTNR1B—gestational diabetes	5.67e-05	0.000403	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—RBP4—gestational diabetes	5.53e-05	0.000393	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GGCT—gestational diabetes	5.5e-05	0.000391	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—FGF2—gestational diabetes	5.48e-05	0.000389	CbGpPWpGaD
Sorafenib—CDK7—Disease—FGF2—gestational diabetes	5.46e-05	0.000388	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GGCT—gestational diabetes	5.46e-05	0.000388	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—FGF2—gestational diabetes	5.42e-05	0.000385	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.24e-05	0.000372	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GLS2—gestational diabetes	5.23e-05	0.000372	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—NAMPT—gestational diabetes	5.17e-05	0.000367	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—GCK—gestational diabetes	5.14e-05	0.000365	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—NAMPT—gestational diabetes	5.13e-05	0.000364	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TNF—gestational diabetes	5.12e-05	0.000363	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GLS2—gestational diabetes	5.1e-05	0.000363	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—GCK—gestational diabetes	5.1e-05	0.000362	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—FGF2—gestational diabetes	5.09e-05	0.000361	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MTNR1B—gestational diabetes	4.9e-05	0.000348	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—FGF2—gestational diabetes	4.88e-05	0.000347	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—FGF2—gestational diabetes	4.88e-05	0.000347	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GLS2—gestational diabetes	4.81e-05	0.000342	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—RBP4—gestational diabetes	4.77e-05	0.000339	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GLS2—gestational diabetes	4.77e-05	0.000339	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.68e-05	0.000332	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GGCT—gestational diabetes	4.66e-05	0.000331	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CYP19A1—gestational diabetes	4.43e-05	0.000315	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CYP19A1—gestational diabetes	4.43e-05	0.000315	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—LEP—gestational diabetes	4.39e-05	0.000312	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TNF—gestational diabetes	4.38e-05	0.000311	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—FGF2—gestational diabetes	4.32e-05	0.000307	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—LEP—gestational diabetes	4.28e-05	0.000304	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.26e-05	0.000303	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GLS2—gestational diabetes	4.08e-05	0.000289	CbGpPWpGaD
Sorafenib—BRAF—Disease—FGF2—gestational diabetes	3.95e-05	0.000281	CbGpPWpGaD
Sorafenib—KIT—Immune System—FGF2—gestational diabetes	3.9e-05	0.000277	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—FGF2—gestational diabetes	3.9e-05	0.000277	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—NAMPT—gestational diabetes	3.79e-05	0.000269	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—GCK—gestational diabetes	3.77e-05	0.000268	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CYP19A1—gestational diabetes	3.76e-05	0.000267	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CYP19A1—gestational diabetes	3.73e-05	0.000265	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—NAMPT—gestational diabetes	3.71e-05	0.000263	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—FGF2—gestational diabetes	3.7e-05	0.000263	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—FGF2—gestational diabetes	3.69e-05	0.000262	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—GCK—gestational diabetes	3.68e-05	0.000262	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—LEP—gestational diabetes	3.68e-05	0.000261	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—LEP—gestational diabetes	3.64e-05	0.000259	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	3.64e-05	0.000259	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GGCT—gestational diabetes	3.6e-05	0.000256	CbGpPWpGaD
Sorafenib—KIT—Disease—FGF2—gestational diabetes	3.6e-05	0.000256	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	3.54e-05	0.000251	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TNF—gestational diabetes	3.51e-05	0.000249	CbGpPWpGaD
Sorafenib—FGFR1—Disease—FGF2—gestational diabetes	3.41e-05	0.000243	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—FGF2—gestational diabetes	3.41e-05	0.000242	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—FGF2—gestational diabetes	3.33e-05	0.000237	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—FGF2—gestational diabetes	3.32e-05	0.000236	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—LEP—gestational diabetes	3.32e-05	0.000236	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—LEP—gestational diabetes	3.32e-05	0.000236	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—FGF2—gestational diabetes	3.25e-05	0.000231	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—NAMPT—gestational diabetes	3.21e-05	0.000228	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—GCK—gestational diabetes	3.19e-05	0.000227	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—LEP—gestational diabetes	3.15e-05	0.000224	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GLS2—gestational diabetes	3.15e-05	0.000223	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—LEP—gestational diabetes	3.14e-05	0.000223	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—FGF2—gestational diabetes	3.07e-05	0.000218	CbGpPWpGaD
Sorafenib—RAF1—Immune System—FGF2—gestational diabetes	2.96e-05	0.00021	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—NAMPT—gestational diabetes	2.87e-05	0.000204	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—GCK—gestational diabetes	2.85e-05	0.000202	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—LEP—gestational diabetes	2.83e-05	0.000201	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—NAMPT—gestational diabetes	2.8e-05	0.000199	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—FGF2—gestational diabetes	2.79e-05	0.000198	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—GCK—gestational diabetes	2.78e-05	0.000197	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—FGF2—gestational diabetes	2.77e-05	0.000197	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CYP19A1—gestational diabetes	2.76e-05	0.000196	CbGpPWpGaD
Sorafenib—RAF1—Disease—FGF2—gestational diabetes	2.73e-05	0.000194	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—LEP—gestational diabetes	2.7e-05	0.000192	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CYP19A1—gestational diabetes	2.69e-05	0.000191	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—NAMPT—gestational diabetes	2.64e-05	0.000187	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—GCK—gestational diabetes	2.62e-05	0.000186	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—NAMPT—gestational diabetes	2.61e-05	0.000186	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—GCK—gestational diabetes	2.6e-05	0.000184	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—LEP—gestational diabetes	2.52e-05	0.000179	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—FGF2—gestational diabetes	2.52e-05	0.000179	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—FGF2—gestational diabetes	2.52e-05	0.000179	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—FGF2—gestational diabetes	2.39e-05	0.00017	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—FGF2—gestational diabetes	2.38e-05	0.000169	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	2.33e-05	0.000166	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NAMPT—gestational diabetes	2.23e-05	0.000159	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—GCK—gestational diabetes	2.22e-05	0.000158	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—LEP—gestational diabetes	2.18e-05	0.000155	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—FGF2—gestational diabetes	2.15e-05	0.000153	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CYP19A1—gestational diabetes	2.08e-05	0.000148	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—FGF2—gestational diabetes	2.05e-05	0.000146	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.03e-05	0.000144	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	1.92e-05	0.000136	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—FGF2—gestational diabetes	1.92e-05	0.000136	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CYP19A1—gestational diabetes	1.9e-05	0.000135	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.72e-05	0.000122	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—GCK—gestational diabetes	1.71e-05	0.000122	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—FGF2—gestational diabetes	1.65e-05	0.000117	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CYP19A1—gestational diabetes	1.62e-05	0.000115	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.25e-05	8.89e-05	CbGpPWpGaD
